https://nl.marketscreener.com/koers/aandeel/TAKEDA-PHARMACEUTICAL-COM-6491073/nieuws/FDA-keurt-EOHILIA-budesonide-orale-suspensie-van-Takeda-goed-45945290/?utm_source=telegram&utm_medium=social&utm_campaign=share